Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
009300
vs
K
KOSPI 200
Over the past 12 months, Sam-A Pharm Co Ltd has underperformed KOSPI 200, delivering a return of -17% compared to KOSPI 200's +50% growth.
Stocks Performance
009300 vs KOSPI 200
Performance Gap
009300 vs KOSPI 200
Performance By Year
009300 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sam-A Pharm Co Ltd
Glance View
Sam-A Pharm Co Ltd is a South Korean pharmaceutical company that makes and sells medicines and drug ingredients. Its business is centered on developing finished drugs and active pharmaceutical ingredients, which are the core chemical inputs used to make medicines. It supplies these products to hospitals, clinics, pharmacies, and other drug companies that need reliable ingredients or ready-to-use treatments. The company earns money by selling prescription and over-the-counter medicines, as well as pharmaceutical ingredients and other drug-related products. In practice, that means it sits in the middle of the healthcare supply chain: sometimes it sells directly to medical and retail customers, and sometimes it sells ingredients to other manufacturers that use them in their own products. What makes this business different is that it combines both drug manufacturing and ingredient supply. That gives Sam-A Pharm a role in two parts of the market at once: the end market for medicines and the upstream market for pharmaceutical raw materials. This mix can make the company less dependent on any single product line and gives it a steady place in the healthcare value chain.